Loading...
Back
SCSP
SPRC
SCISPARC LTD
(SPRC)
2026 6-K
Follow
Summary
Share
Summary
Patent Collaboration
16 Mar '26
Acquisition Announcement
12 Mar '26
Share Split Announcement
2 Mar '26
Funding Update
17 Feb '26
Funding Agreement
12 Feb '26
Shareholder Approval
4 Feb '26
Patent Granted
2 Feb '26
IP Acquisition Completed
26 Jan '26
New Share Offering
13 Jan '26
Patent Acquisition
13 Jan '26
Stockholder Equity Alert
12 Jan '26
Accounting Firm Change
31 Dec '25
Stake Acquisition
2 Dec '25
Securities Purchase Agreement
28 Nov '25
Patent Acquisition
26 Nov '25
Patent Announcement
20 Nov '25
Financial Report
18 Nov '25
Company Acquisition
27 Oct '25
Subsidiary Sale Closed
24 Oct '25
Asset Acquisition
15 Oct '25
Framework Agreement Update
6 Oct '25
Merger Announcement
30 Sep '25
Warrant Exercise Agreement
26 Sep '25
Management Changes
25 Sep '25
Merger Update
16 Sep '25
Investigation Update
8 Sep '25
Conversion of Debentures
29 Aug '25
Merger Approval
28 Aug '25
Shareholder Meeting Approved
26 Aug '25
Meeting Adjourned
25 Aug '25
Patent Collaboration
8 Aug '25
Merger Update
31 Jul '25
Share Split Report
22 Jul '25
Compliance Regained
22 Jul '25
Shareholder Approval
26 Jun '25
Annual Meeting Update
25 Jun '25
Share Split Announced
24 Jun '25
Merger Agreement Update
9 Jun '25
Patent Application Filed
27 May '25
Annual Meeting Notice
21 May '25
Patent Announcement
13 May '25
Patent Application Filed
25 Apr '25
Spin-Off Update
1 Apr '25
Merger Update
1 Apr '25
Patent Publication Update
11 Mar '25
Sale Agreement
3 Mar '25
Securities Deal
27 Feb '25
Legal Settlement Secured
18 Feb '25
Patent Announcement
4 Feb '25
Nasdaq Extension Granted
15 Jan '25
Patent Publication Announce...
7 Jan '25
Approval Renewal
31 Dec '24
Vehicle Delivery Announcement
26 Dec '24
Spin-off Update
17 Dec '24
Merger Announcement
29 Nov '24
Merger Agreement Update
27 Nov '24
Financial Report
4 Nov '24
Shareholder Approval
23 Oct '24
Annual Meeting Update
22 Oct '24
Meeting Postponed
27 Sep '24
Stake Sale Intent
26 Sep '24
FDA Approval Announcement
23 Sep '24
Patent Collaboration
16 Sep '24
Loan Amendment
11 Sep '24
SciSparc Patent News
6 Sep '24
Collaboration Announcement
29 Aug '24
FDA Application Filed
26 Aug '24
Annual Meeting Notice
22 Aug '24
Clinical Trial Update
20 Aug '24
Patent License Agreement
19 Aug '24
Merger Update
14 Aug '24
Merger Approval Update
13 Aug '24
New Drug Potential
6 Aug '24
Cancer Drug Update
23 Jul '24
Licensing Agreement
17 Jul '24
Nasdaq Notification
16 Jul '24
Patent Announcement
16 Jul '24
Spin-off Announcement
8 Jul '24
Loan Agreement Update
14 Jun '24
Patent Grant News
3 Jun '24
Merger Announcement
2 May '24
Merger Announcement
11 Apr '24
Patent Collaboration News
27 Mar '24
Clinical Trial Milestone
15 Mar '24
MitoCareX Update
13 Mar '24
New Patents Announced
8 Mar '24
New Clinical Trial
29 Feb '24
Patent Applications Filed
27 Feb '24
Patent Portfolio Update
20 Feb '24
License Termination Alert
12 Feb '24
Clinical Trial Launch
29 Jan '24
Equity Purchase Agreement
25 Jan '24
Acquisition Process
22 Jan '24
External Links:
SEC
On February 4, 2026, SciSparc Ltd. shareholders approved all proposals at a special general meeting, as required by Israeli law.
AI Assistant
Close
SCISPARC LTD
2026
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.